Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > YKL-40 as a clinical biomarker in adult patients with CF: Implications of a CHI3L1 single nucleotide polymorphism in disease severity.

YKL-40 as a clinical biomarker in adult patients with CF: Implications of a CHI3L1 single nucleotide polymorphism in disease severity.

Resource Type

CF Research News

Authors

Adèle Coriati, Guillaume F Bouvet, Chantal Massé, Thierry Ducruet, Yves Berthiaume

References

J Cyst Fibros. 2020 Dec 1;S1569-1993(20)30914-0. doi: 10.1016/j.jcf.2020.11.011.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

CHI3L1 [3]
Disease severity [4]
Single nucleotide polymorphism [5]
YKL-40 [6]

Date

Tuesday, December 1, 2020

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/ykl-40-clinical-biomarker-adult-patients-cf-implications-chi3l1

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-20-00386R2_FINAL_Coriati_020321.pdf [2] https://pubmed.ncbi.nlm.nih.gov/33277205/ [3] https://www.ecfs.eu/research-article-keywords/chi3l1 [4] https://www.ecfs.eu/research-article-keywords/disease-severity [5] https://www.ecfs.eu/research-article-keywords/single-nucleotide-polymorphism [6] https://www.ecfs.eu/research-article-keywords/ykl-40 [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines